<DOC>
	<DOCNO>NCT01704573</DOCNO>
	<brief_summary>This positron emission tomography ( PET ) study examines effect 24 hour abstinence smoke return availability neuronal nicotinic receptor slow fast metabolizers nicotine .</brief_summary>
	<brief_title>Nicotinic Receptor Levels After Stopping Smoking</brief_title>
	<detailed_description>The nicotine metabolite ratio ( NMR ) , stable marker nicotine clearance rate , robust predictor smoking relapse . Individuals fast nicotine metabolizers higher rate relapse , compare slow metabolizers , nicotine replacement placebo treatment . Nicotine exert reinforce property , part , bind α4β2* nicotinic acetylcholine receptor ( nAChRs ) brain . The α4β2* nAChRs abundant high affinity nicotine relative nAChR subtypes . The goal project identify abstinence-induced change neuronal nicotinic receptor availability may underlie risk smoking relapse . The investigator propose utilize positron emission tomography ( PET ) image examine association variation nicotine metabolism return availability α4β2* nAChRs early abstinence . The investigator measure α4β2* receptor availability use PET radio-ligand 2- [ 18F ] FA , administer bolus injection , two separate occasion : smoke usual 24 hour abstinence . The propose study help u understand neurochemical mechanism underlie high risk relapse among fast nicotine metabolizers , thereby point potential target tailor therapy smoker increase risk . In addition , investigator invite six subject complete two PET scan describe complete third PET scan . During third PET scan , investigator plan measure α4β2* receptor availability use PET radio-ligand 2- [ 18F ] FA , administer bolus plus constant infusion 24 hour abstinence . The purpose compare α4β2* nAChR bind potential data bolus 2- [ 18F ] FA infusion protocol use main study bolus plus constant infusion protocol use third PET scan . The protocol third PET scan help investigator demonstrate feasibility University Pennsylvania administer radiotracer bolus plus constant infusion , feasibility scan two hour ( versus one hour current protocol ) paradigm . This data important pilot data future NIH grant submission use radiotracer .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>1 . Ages 18 65 year old . 2 . Smoke 10 cigarette per day previous 6 month . 3 . Weigh le 300lbs ( due limitation PET MRI scanner ) . 1 . Smoking behavior : 1 . Current enrollment plan enroll smoke cessation program , use smoke cessation medication next 2 month . 2 . Provide CO read less 10 ppm medical screening . 2 . Alcohol/Drugs : 1 . History substance abuse and/or currently receive treatment substance abuse ( e.g. , alcohol , opioids , cocaine , marijuana , stimulant ) . 2 . Positive drug screen session ( see page 8 list drug and/or contraindicate medication ) . 3 . Current alcohol consumption exceed 25 standard drinks/week . 4 . Providing breath alcohol concentration ( BrAC ) read great equal 0.01 session . 3 . Medical : 1 . Women pregnant , planning pregnancy , lactate ; female subject shall undergo serum pregnancy test medical screening session urine pregnancy test two PET scan MRI scan . 2 . Women childbearing age must agree write use approve method contraception agree abstain sexual intercourse 3 . History current diagnosis follow psychiatric diagnosis identify MINI ( Mini International Neuropsychiatric Interview ) psychosis , bipolar disorder , schizophrenia , major current depression , Axis 1 disorder 4 . Selfreport serious unstable disease within past 6 month ( e.g. , cancer [ except melanoma ] , HIV/AIDS , stroke , angina , coronary disease , heart attack ) . 5 . History epilepsy seizure disorder . 6 . Any medical neurological condition might interfere distribution radiotracer determine study M.D . 4 . Medication : . Current use recent discontinuation ( within last 14days ) follow medication : Any form smoking cessation medication ( Zyban , Wellbutrin , Wellbutrin SR , Chantix , NRT ) ; Recent ( within last 14 day ) plan use psychotropic medication ( antipsychotic , antidepressant , antianxiety , antipanic medication , mood stabilizer , opioids , stimulant ) . Participants shall instruct refrain use study prohibit drug ( note participant allow take prescription medicine exclusion list ) throughout participation study . 5 . ImagingRelated 1 . Selfreported history head trauma brain ( CNS ) tumor . 2 . Selfreported history claustrophobia ( contraindicate PET MRI ) . 3 . Having cochlear implant wear bilateral hearing aid . 4 . Selfreported use pacemaker , certain metallic implant , presence metal eye contraindicate MRI . 5 . History gunshot wound . 6 . Circumstances condition may interfere magnetic resonance imaging ( MRI ) 7 . Inability complete baseline study procedure within four hour and/or correctly , determine PI .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>PET Scan</keyword>
</DOC>